Chemoinformaics analysis of 4-HYDROXYACETOPHENONE
| Molecular Weight | 136.15 | nRot | 1 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 7 |
| Exact Molecular Weight | 136.052 | nRing | 1 |
| Solubility: LogS | -1.127 | nHRing | 0 |
| Solubility: LogP | 1.24 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 20.2983 |
| nHD | 1 | BPOL | 8.89366 |
| QED | 0.595 |
| Synth | 1.42 |
| Natural Product Likeliness | 0.141 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.01 |
| HIA | 0.005 |
| CACO-2 | -4.411 |
| MDCK | 0.000019 |
| BBB | 0.218 |
| PPB | 0.632693 |
| VDSS | 0.675 |
| FU | 0.337795 |
| CYP1A2-inh | 0.942 |
| CYP1A2-sub | 0.55 |
| CYP2c19-inh | 0.565 |
| CYP2c19-sub | 0.085 |
| CYP2c9-inh | 0.135 |
| CYP2c9-sub | 0.897 |
| CYP2d6-inh | 0.08 |
| CYP2d6-sub | 0.708 |
| CYP3a4-inh | 0.083 |
| CYP3a4-sub | 0.282 |
| CL | 9.422 |
| T12 | 0.877 |
| hERG | 0.04 |
| Ames | 0.066 |
| ROA | 0.538 |
| SkinSen | 0.283 |
| Carcinogencity | 0.638 |
| EI | 0.994 |
| Respiratory | 0.295 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.888946 |